Drug Shortage Report for HALOPERIDOL LA
Report ID | 62723 |
Drug Identification Number | 02130300 |
Brand name | HALOPERIDOL LA |
Common or Proper name | HALOPERIDOL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | HALOPERIDOL |
Strength(s) | 100MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR |
Packaging size | 5ML VIAL |
ATC code | N05AD |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-09-17 |
Estimated end date | |
Actual end date | 2017-09-29 |
Shortage status | Resolved |
Updated date | 2018-10-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-10-04 | French | Compare |
v3 | 2018-10-04 | English | Compare |
v2 | 2018-09-30 | French | Compare |
v1 | 2018-09-30 | English | Compare |
Showing 1 to 4 of 4